The Potential of Metabolomics in Colorectal Cancer Prognosis
Author Information
Author(s): Fu Chengqu, Liu Xinyi, Wang Le, Hang Dong
Primary Institution: Nanjing Medical University
Hypothesis
Can metabolomics provide reliable biomarkers for predicting the prognosis of colorectal cancer?
Conclusion
Metabolomics shows promise in identifying biomarkers that can predict the prognosis of colorectal cancer, but further high-quality research is needed.
Supporting Evidence
- Metabolomics can identify biomarkers for colorectal cancer prognosis.
- Studies show that metabolic profiles can differentiate between cancer stages.
- High-throughput techniques like LC-MS are effective for metabolomic analysis.
- Certain metabolites are consistently associated with cancer recurrence.
- Integration of metabolomics with other omics approaches could enhance understanding.
Takeaway
Scientists are studying tiny substances in our body to help doctors predict how well patients with colon cancer will do in the future.
Methodology
This review analyzes various studies on metabolomics and its association with colorectal cancer prognosis, including methods like NMR and LC-MS.
Potential Biases
Variations in sample size, participant criteria, and analytical methods may introduce bias.
Limitations
Many studies had small sample sizes and lacked external validation.
Participant Demographics
The studies included diverse populations from China, the United States, and Europe.
Statistical Information
P-Value
0.0005
Confidence Interval
95% CI = 1.50-NA
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website